Though we focus on helping Payers, Providers, RHIOs, and NGOs, Strategic Interests often finds we are in a position to provide strategic consulting to innovative healthcare technology companies. One of our favorites is DayTwo, a startup from Israel that is using microbiome technology to predict which foods will raise a person’s blood glucose and which will not. Did you know this differs for each person? Can you imaging having a list of the foods that are better for your personal nutrition based on your individual gut makeup? Many people think this is simple — eat an apple, not a doughnut. But it’s not as simple as that when you are comparing an apple to an orange. Or beer to wine. Or pretzels to chips. And these choices do make a difference in blood sugar response. DayTwo’s analytics are based on excellent research from the Weizmann Institute of Science in Israel and take the complicated test result data and yield an easy to use interface for patients and providers to apply the personalized nutrition information.
When DayTwo wanted to bring their technology to the United States, they asked Strategic Interests to help them set up a pilot program at a prestigious medical institution. We could think of no better choice than the Mayo Clinic. SI worked to make the introductions and facilitated a successful arrangement between these two innovative organizations.
Recent Comments